Pratt Raymond Dennis
Insider transactions at 2 companies
This page shows all SEC Form 4 filings attributed to Pratt Raymond Dennis. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| SVRA | Chief Medical Officer | Award / Grant | 80,000 | — | — | Dec 12, 2024 |
| SVRA | Chief Medical Officer | Tax Withholding | 49,950 | $3.97 | $198,302 | Nov 10, 2024 |
| SVRA | Chief Medical Officer | Award / Grant | 150,000 | — | — | Dec 14, 2023 |
| SVRA | Chief Medical Officer | Purchase | 6,500 | $2.93 | $19,045 | Jun 26, 2023 |
| SVRA | Chief Medical Officer | Purchase | 3,500 | $1.54 | $5,390 | Dec 22, 2022 |
| SVRA | Chief Medical Officer | Award / Grant | 150,000 | — | — | Nov 21, 2022 |
| RMTI | VP of Drug Development | Tax Withholding | 4,612 | $2.27 | $10,469 | Apr 26, 2020 |
| RMTI | Chief Medical Officer | Award / Grant | 40,000 | — | — | Apr 25, 2019 |
| RMTI | VP of Drug Development | Tax Withholding | 76,230 | $7.20 | $548,856 | Jun 21, 2017 |
| RMTI | VP of Drug Development | Award / Grant | 68,500 | — | — | Mar 21, 2017 |
| RMTI | VP of Drug Development | Award / Grant | 165,000 | — | — | Oct 2, 2015 |
| RMTI | VP of Drug Development | Purchase | 4,912 | $11.54 | $56,684 | Aug 13, 2015 |
| RMTI | VP of Drug Development | Tax Withholding | 34,650 | $9.64 | $334,026 | May 1, 2015 |
| RMTI | VP of Drug Development | Tax Withholding | 34,650 | $10.47 | $362,786 | Mar 2, 2015 |
| RMTI | VP of Drug Development | Award / Grant | 75,000 | — | — | Oct 1, 2014 |
| RMTI | VP of Drug Development | Award / Grant | 75,000 | — | — | Jan 13, 2014 |
| RMTI | VP of Drug Development | Award / Grant | 75,000 | — | — | Jun 14, 2013 |